If you’ve been diagnosed with Type 2 diabetes, you’ve almost certainly been told some version of the same story. Your blood sugar is too high. You need to reduce sugar and refined carbohydrates. Here is a medication to help manage your glucose levels. Come back in three months and we’ll recheck your A1c.
What you probably haven’t been told is why your blood sugar got too high in the first place, beyond the generic answer of diet and lifestyle. You haven’t been told what’s happening at the cellular level that made your body stop responding normally to insulin. You haven’t been told whether there are physiological drivers of your insulin resistance that have nothing to do with what you eat. And you haven’t been told that for a significant proportion of people with Type 2 diabetes, the condition is not the inevitable chronic disease it’s presented as but the downstream result of identifiable, addressable physiological dysfunction.
That conversation, the one about what’s actually driving your Type 2 diabetes and what addressing those drivers might make possible, is the one that rarely happens in conventional diabetes care. And it’s the one that changes everything for the patients who finally have it.
Conventional diabetes management is built around a treatment framework that focuses primarily on glucose control. Medications lower blood sugar. Dietary guidelines reduce glucose and insulin load. Regular monitoring tracks A1c as a measure of average blood sugar control. These interventions manage the downstream metabolic consequence of insulin resistance. They don’t address why insulin resistance developed or what’s sustaining it.
This isn’t a failure of intent. It’s a structural limitation of a system designed around disease management rather than root cause resolution. The 15 to 20 minute appointment that governs most primary care and endocrinology visits doesn’t create space for the kind of thorough history-taking and comprehensive evaluation that identifying the specific drivers of insulin resistance in an individual patient requires. The standard testing protocol for diabetes, fasting glucose and A1c, provides enough information to diagnose and monitor the condition but not enough to understand its specific physiological roots.
According to research published in the New England Journal of Medicine, Type 2 diabetes is a heterogeneous condition, meaning the same diagnosis can reflect significantly different underlying pathophysiology in different patients. Treating it as a uniform condition with a uniform management protocol produces uniform, partial results across a population of patients whose actual drivers are diverse and individual.
The root cause conversation requires time, thorough evaluation, and a clinical framework that asks different questions than conventional diabetes management does. It asks not just “how do we lower this person’s blood sugar” but “why is this person’s blood sugar elevated, what specific physiological drivers are sustaining their insulin resistance, and what does addressing those drivers make possible.”
Diet is a genuine and significant contributor to insulin resistance, and addressing dietary patterns is an important part of any meaningful diabetes intervention. But diet is not the only driver, and for many people it’s not even the primary one. Understanding the full range of physiological contributors to insulin resistance changes how comprehensively the condition can be addressed.
Chronic stress and cortisol dysregulation are among the most clinically significant and most consistently overlooked drivers of insulin resistance. Cortisol directly antagonizes insulin action at the receptor level, promotes gluconeogenesis (the production of glucose from non-carbohydrate sources), drives visceral fat deposition around the abdominal organs, and disrupts sleep in ways that compound metabolic dysfunction. According to research published in Diabetes Care, chronic psychological stress is an independent risk factor for Type 2 diabetes development, with a dose-dependent relationship between stress burden and diabetes risk that persists after controlling for dietary and lifestyle factors.
For patients whose diabetes developed or significantly worsened during a period of sustained high stress, or whose blood sugar control fluctuates in patterns that track with stress levels, the HPA axis is a central piece of the clinical picture that standard diabetes management doesn’t evaluate or address.
Sleep disruption and sleep apnea have a well-established and bidirectional relationship with insulin resistance that receives almost no attention in conventional diabetes care. According to research published in Sleep Medicine Reviews, sleep deprivation impairs insulin sensitivity through effects on cortisol secretion, growth hormone release, and sympathetic nervous system activation that are independent of dietary intake. A single week of sleeping five to six hours per night produces measurable insulin resistance in otherwise healthy individuals, and the effect compounds rapidly with chronic sleep restriction.
Sleep apnea, which is both significantly more common in people with Type 2 diabetes and an independent driver of insulin resistance through repeated nocturnal cortisol and adrenaline surges, deserves evaluation in every diabetes patient whose sleep quality is poor or whose fatigue is disproportionate to their sleep duration. Treating sleep apnea has documented beneficial effects on glucose control that are independent of other interventions.
Gut microbiome dysbiosis has a growing and increasingly well-characterized relationship with insulin resistance and Type 2 diabetes. According to a meta-analysis published in Gut, people with Type 2 diabetes have measurably different gut microbiome compositions compared to healthy controls, with reduced populations of specific beneficial bacterial species that produce short-chain fatty acids important for insulin sensitivity and metabolic regulation. Gut-derived inflammation from dysbiosis and intestinal permeability creates systemic inflammatory conditions that impair insulin signaling at the cellular level through mechanisms that are independent of dietary glucose load.
The gut microbiome’s influence on GLP-1 and other incretin hormones that regulate glucose-stimulated insulin secretion adds another dimension to the gut-diabetes relationship that is increasingly recognized in the research but rarely incorporated into clinical diabetes management.
Thyroid dysfunction impairs insulin sensitivity and glucose metabolism through multiple mechanisms and is significantly more common in people with Type 2 diabetes than in the general population. According to research published in the Journal of Thyroid Research, hypothyroidism reduces glucose uptake in peripheral tissues, impairs insulin receptor sensitivity, and slows the metabolic rate in ways that contribute to visceral fat accumulation and worsening insulin resistance. Identifying and addressing thyroid dysfunction in a diabetes patient produces improvements in glucose control that medication adjustments alone cannot replicate.
Environmental toxin burden is an area of diabetes research that has grown substantially in the last two decades and that receives almost no attention in clinical diabetes management. Persistent organic pollutants, heavy metals including arsenic and cadmium, and endocrine-disrupting compounds have documented effects on insulin receptor signaling, pancreatic beta cell function, and systemic inflammation that contribute to both insulin resistance and beta cell loss. According to research published in Environmental Health Perspectives, serum concentrations of persistent organic pollutants show a dose-dependent association with Type 2 diabetes prevalence that persists after controlling for obesity and other conventional risk factors.
Nutrient deficiencies in areas critical for glucose metabolism are extremely common in people with Type 2 diabetes and are rarely assessed in standard diabetes care. Magnesium is particularly important: it functions as an essential cofactor for insulin receptor tyrosine kinase, the enzyme that initiates insulin signaling at the cellular level, and deficiency directly impairs insulin action. According to a meta-analysis published in Diabetes Care, hypomagnesemia is present in approximately 25 to 38% of people with Type 2 diabetes and is associated with significantly poorer glycemic control independent of other factors.
The research on Type 2 diabetes reversal, meaning the achievement of normal blood sugar without medication, has advanced significantly and consistently over the last decade in ways that haven’t fully penetrated clinical practice.
The DiRECT trial, published in The Lancet in 2018, demonstrated that a structured dietary intervention produced diabetes remission, defined as A1c below 6.5% without medication, in 46% of participants at 12 months. The degree of remission correlated directly with the amount of visceral fat reduction achieved, supporting research from the Newcastle group showing that ectopic fat deposition in the liver and pancreas is a central and reversible mechanism of metabolic dysfunction in Type 2 diabetes.
Research on low-carbohydrate dietary interventions has produced similarly compelling results, with multiple studies showing A1c reductions comparable to pharmaceutical treatment and significant proportions of participants achieving medication reduction or elimination under clinical supervision. A 2019 study published in Diabetes Therapy found that 60% of participants in a continuous care low-carbohydrate intervention achieved A1c below 6.5% at one year, with 94% of insulin users reducing or eliminating insulin.
These results don’t happen because of better medication management. They happen because something about the metabolic environment changed fundamentally. Understanding what needs to change in any individual patient’s metabolic environment, and what combination of interventions will produce that change most effectively for their specific physiological picture, is the clinical question that a root cause evaluation is designed to answer.
The difference between standard diabetes management and a root cause approach isn’t primarily the tools used. It’s the questions asked, the depth of evaluation conducted, and the comprehensiveness of what the care plan addresses.
At True Health Clinic, a root cause evaluation for Type 2 diabetes or insulin resistance begins with a thorough history that covers the full timeline of metabolic changes, what was happening in the patient’s life when their blood sugar first became a clinical concern, their sleep quality, their stress history, their gut health, their hormonal picture, their environmental history, and any previous diagnoses or treatments that inform the full clinical picture.
The testing ordered reflects what the history and clinical picture suggest rather than a standard protocol applied to a diagnosis. Fasting insulin alongside fasting glucose provides a more complete metabolic picture than glucose or A1c alone. Thyroid evaluation, hormone assessment, gut health assessment, nutrient status evaluation, and inflammatory markers each contribute pieces of information that standard diabetes monitoring doesn’t capture and that shape the care plan in meaningful ways.
The care plan built from that evaluation is personalized to the individual’s specific drivers, addresses them in a logical sequence, and is monitored and adjusted as the clinical picture evolves. The goal is always to understand what’s actually sustaining the insulin resistance in this specific patient and to address that as comprehensively as possible, not to optimize glucose numbers within a management framework that leaves the underlying dysfunction in place.
For patients in Wichita, Hesston, and the surrounding areas of Kansas who have been managing Type 2 diabetes and want to understand what a root cause approach might make possible for their specific situation, a free 15-minute phone consultation is the starting point for that conversation.
Book Your Free 15-Minute Consultation
Note: This article is intended for educational purposes and should not be used to diagnose or treat any medical condition. If you’re experiencing symptoms discussed in this article, consult a qualified healthcare professional for personalized guidance.
| PHOTOGRAPHY BY lauragonzalezphotography.com | Made by a Peanut |